Intraoperative radiotherapy might not serve as a standard therapy for retroperitoneal liposarcoma: insights from a population-based propensity score-matched study
As an exploratory study, our findings suggest that patients may not derive benefit from intraoperative radiotherapy. These observations are intended to lay the groundwork for future prospective clinical studies.
Authors
- Xiao Zhou (ORCID: https://orcid.org/0000-0002-7229-9473)
- C Y Zhang (ORCID: https://orcid.org/0000-0002-3731-712X)
- Fuan Xie
- Wengang Li (ORCID: https://orcid.org/0000-0002-6980-1776)
- Aobo Zhuang (ORCID: https://orcid.org/0000-0002-3958-7975)
- Guangting Yan
- Xin Ma (ORCID: https://orcid.org/0000-0002-7316-1468)
- Xi Li (ORCID: https://orcid.org/0000-0001-7106-1677)
- Gen Zhang (ORCID: https://orcid.org/0000-0001-8619-3285)
- Ting Wu (ORCID: https://orcid.org/0000-0003-4021-6298)
- Yangyang Huang (ORCID: https://orcid.org/0009-0001-8694-5755)
- Zhe Xi
- Yingxue Cheng
- Yue Wang (ORCID: https://orcid.org/0000-0002-3241-6356)
Institutions
- Harvard University (US)
- Xiamen University (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2024-10-25
- DOI
- https://doi.org/10.3389/fonc.2024.1431920
- Citations
- 2
- Primary Topic
- Sarcoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.84